FDA UNTITLED_LETTER - LEESAR, INC - October 29, 2021

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This UNTITLED LETTER record concerns LEESAR, INC, with an inspection on October 29, 2021, issued by the Office of Pharmaceutical Quality, covering drugs.

Company: LEESAR, INC
Inspection Date: October 29, 2021
Product Type: Drugs
Office: Office of Pharmaceutical Quality
People: James R. Boswell
José R. Lopez (Program Expert)
Mark W. Rivero (Compliance Officer)

Open in Dashboard

ID · 8be237a3-e954-4817-8ae4-f0842ff3fda4

Violation Codes8

21 U.S.C. 360eee-121 U.S.C. 351(a)(2)(A)21 CFR 21021 U.S.C. 353b21 CFR 211.19221 U.S.C. 351(a)(2)(B)21 U.S.C. 355(a)21 CFR 201.115

Full citation text and observation details available on the Dashboard.